Prime Medicine, Inc. (PRME) Operating cash flow 2020–2025
Prime Medicine, Inc. (PRME) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$162.6MFY2025 · since FY2020: -$5.5M → -$162.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.6M | -32.3% |
| FY2024 | -$122.9M | +25.7% |
| FY2023 | -$165.4M | -25.5% |
| FY2022 | -$131.8M | -286.8% |
| FY2021 | -$34.1M | -514.8% |
| FY2020 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice